We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

683:HKEXKerry Properties Limited Analysis

Data as of 2026-03-17 - not real-time

HK$7.77

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Green Tea Group is trading at HK$7.77, comfortably above its 20‑day (HK$7.34), 50‑day (HK$7.12) and 200‑day (HK$6.95) simple moving averages, indicating a bullish price trend. The RSI of 61 and a bullish MACD histogram (+0.06) reinforce forward momentum, while the stock sits near its technical support of HK$6.70 and below the near‑term resistance of HK$7.98. Volatility remains high at 38% over the past 30 days, yet beta is exceptionally low (0.07), suggesting price swings are largely company‑specific rather than market‑driven.
Fundamentally, revenue is expanding at a robust 23% YoY with solid gross (38%) and operating (13%) margins, and forward earnings per share are projected to rise to HK$1.03, driving the forward P/E down to 7.6x. The balance sheet shows net cash (cash HK$1.35bn vs debt HK$1.14bn) and positive operating cash flow, though free cash flow is currently flat and ROE/ROA are reported as zero, flagging potential accounting quirks. Analysts’ consensus is a strong buy with a mean target price of HK$11.53, implying roughly 48% upside from the current level.
Given the stark disparity between the DCF‑derived fair value of HK$37.80 and the market price, the stock appears significantly undervalued. The combination of strong growth metrics, modest valuation multiples (P/E 11.3x, P/B 2.6x) and an “Extreme Greed” market sentiment supports a bullish outlook, while the primary risks stem from high volatility, medium regulatory and geographic exposure, and a leveraged balance sheet.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Price above key moving averages
  • Bullish MACD and RSI in the 60s
  • Decreasing volume and proximity to resistance

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • 23% revenue growth and expanding margins
  • Forward P/E of 7.6x indicating cheap earnings
  • Analyst target price suggesting ~48% upside

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • DCF fair value far exceeds market price
  • Net cash position and strong operating cash flow
  • Resilient brand presence in China’s consumer‑cyclical sector

Key Metrics & Analysis

Financial Health

Revenue Growth23.10%
Profit Margin9.59%
P/E Ratio11.3
Debt/Equity65.44
P/B Ratio2.6
Op. Cash FlowHK$1.0B

Technical Analysis

TrendBullish
RSI61.4
SupportHK$6.70
ResistanceHK$7.98
MA 20HK$7.34
MA 50HK$7.12
MA 200HK$6.94
MACDBullish
VolumeDecreasing
Fear & Greed Index79.14

Valuation

Fair ValueHK$37.80
Target PriceHK$11.53
Upside/Downside48.34%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta0.07
Volatility37.77%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.